Today: 9 April 2026
Rocket Lab stock rebounds as year-end turbulence keeps Space Force contract in focus

Rocket Lab stock rebounds as year-end turbulence keeps Space Force contract in focus

NEW YORK, December 29, 2025, 10:17 ET — Regular session

  • Rocket Lab shares rose about 2.4% in early New York trading, recovering some of Friday’s sharp drop. MarketBeat+1
  • Investors continued to focus on the company’s $816 million Space Development Agency satellite award signed earlier this month. SEC+1
  • Broader U.S. indexes slipped as heavyweight tech stocks retreated in holiday-thinned trading.

Rocket Lab Corp shares rose 2.4% to $72.36 by 10:11 a.m. ET on Monday, a bounce after last week’s sharp swings. MarketBeat

The move matters because Rocket Lab’s stock has been whipsawed by defense-contract headlines into year-end, a period when thin volumes can exaggerate price moves. Shares jumped 17.7% on Dec. 19 and nearly 10% on Dec. 22 before sliding 8.5% on Friday, historical pricing showed. Observer News Enterprise

Investors are still digesting what the company’s latest Space Development Agency award could mean for Rocket Lab’s push beyond its small-launch roots into higher-value national security satellite work. The company builds and launches the Electron rocket and sells spacecraft and satellite components. GlobeNewswire

Rocket Lab ended Friday at $70.65 after hitting an intraday high of $79.83 on Dec. 24, near a record, according to historical quotes. Observer News Enterprise

A Dec. 17 agreement with the Space Development Agency carries a total value of $816 million, including a $806 million base and $10 million of options, a regulatory filing showed. Work begins immediately, with final delivery of the satellites for launch expected in 2029. SEC

The agreement allows either party to terminate “for convenience,” a provision that can let a customer end a contract without alleging breach, subject to conditions in the agreement, the filing said. SEC

The satellite win is part of a larger Space Development Agency push. The agency said it reached agreements worth about $3.5 billion collectively with Lockheed Martin, L3Harris Technologies, Northrop Grumman and Rocket Lab to build 72 infrared satellites, with each supplier contracted for 18 spacecraft. Reuters

The contracts are fixed-price, meaning the contractor agrees to deliver work for a set amount, leaving cost overruns more likely to pressure margins. The satellites are expected to be launched into low-Earth orbit in 2029, Reuters reported. Reuters

Rocket Lab said the Tracking Layer satellites will carry its Phoenix infrared sensor payload and its StarLite space protection sensors, and it flagged additional subsystem opportunities that “could take the total capture value to approximately $1 billion.” GlobeNewswire

“Rocket Lab is honored to play a role in enabling this,” founder and CEO Peter Beck said in the Dec. 19 release. GlobeNewswire

Rocket Lab’s gain came as U.S. indexes slipped. The Nasdaq Composite was down about 0.6% around 9:35 a.m. ET as technology shares pulled back, Reuters reported.

Traders are now watching whether Rocket Lab can hold above the $70 area — near Friday’s close — while the stock remains below last week’s $79.83 intraday peak. Observer News Enterprise

Next catalysts include quarterly results expected in late February, with MarketBeat estimating Feb. 26 after the market close and noting the company has not confirmed a date. Launch trackers list Rocket Lab’s next Electron mission in January 2026, though schedules are subject to change. MarketBeat+1

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
SoftBank’s DigitalBridge buyout jolts thin year-end trading as U.S. futures dip
Previous Story

SoftBank’s DigitalBridge buyout jolts thin year-end trading as U.S. futures dip

Robinhood slips after Needham trims target to $135 as crypto-linked stocks ease
Next Story

Robinhood slips after Needham trims target to $135 as crypto-linked stocks ease

Go toTop